Cargando…
α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
Abnormal sialylation due to overexpression of sialyltransferases has been associated with tumorigenesis and tumor progression. Although ST6Gal-I influences cancer persistence and progression by affecting various receptors, the underlying mechanisms and mediators remain largely obscure, especially in...
Autores principales: | Zhao, Y, Wei, A, Zhang, H, Chen, X, Wang, L, Yu, X, Yuan, Q, Zhang, J, Wang, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523073/ https://www.ncbi.nlm.nih.gov/pubmed/28553930 http://dx.doi.org/10.1038/oncsis.2017.40 |
Ejemplares similares
-
Retraction Note: α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway
por: Zhao, Y., et al.
Publicado: (2020) -
Production of α2,6-sialylated IgG1 in CHO cells
por: Raymond, Céline, et al.
Publicado: (2015) -
Methionine improves feather follicle development in chick embryos by activating Wnt/β-catenin signaling
por: Chen, M.J., et al.
Publicado: (2020) -
α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth
por: GC, Sajina, et al.
Publicado: (2022) -
SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex
por: Zhao, S-J, et al.
Publicado: (2018)